Finally, our results suggest that a selective calpain-2 inhibitor might be beneficial not only for the treatment of TBI, but also for preventing the development of CTE following repeated concussions, as well as for more chronic neurodegenerative disorders such as AD and PD. The gene discussed is CAPN2; the disease is Alzheimer disease.